Daily BriefsSouth Korea

Daily Brief South Korea: Celltrion Healthcare , Lf Corp and more

In today’s briefing:

  • Celltrion Merger Update: Limits Lifted
  • Korea Small Cap Gem #26: LF Corp – A Deep Value Play and the Lee Hyori Effect


Celltrion Merger Update: Limits Lifted

By David Blennerhassett

  • Back on the 17 August, biopharmaceuticals developer and producer Celltrion Inc (068270 KS) announced a merger with Celltrion Healthcare (091990 KS).
  • On October 23rd, shareholders approved the merger. The appraisal rights exercise period commenced on the 23 October and ends on November 13. 28th December is the merger’s effective date.
  • Initially, the stock purchase rights limit was set at 1₩tn; however Celltrion Group’s founder/Chairman Seo Jung-jin has removed this limit. That takes care of NPS, which opposes the merger.

Korea Small Cap Gem #26: LF Corp – A Deep Value Play and the Lee Hyori Effect

By Douglas Kim

  • Lf Corp (093050 KS) is the 26th company in our Korea Small Cap Gems series. 
  • LF Corp is one of the leading apparel companies in Korea which has a market cap of 411 billion won. LF Corp is trading at 0.3x P/B and 4x P/E.
  • A key near-term catalyst is better than expected sales of the Reebok branded apparel that are promoted by the pop icon Lee Hyori. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars